인돌아민 2,3-이산소화효소 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "인돌아민 2,3-이산소화효소" in Korean language version.

refsWebsite

Global rank Korean rank

27nih.gov

4^th place

25doi.org

2^nd place

3^rd place

7worldcat.org

5^th place

11^th place

4harvard.edu

18^th place

27^th place

3archive.org

6^th place

18^th place

2ensembl.org

1,626^th place

501^st place

archive.org

“Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci”. 《The Journal of Infectious Diseases》 178 (3): 875–8. September 1998. doi:10.1086/515347. PMID 9728563.
“Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections”. 《Journal of Virology》 78 (5): 2632–6. March 2004. doi:10.1128/jvi.78.5.2632-2636.2004. PMC 369218. PMID 14963171.
“Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon”. 《Journal of Virology》 79 (12): 7768–76. June 2005. doi:10.1128/jvi.79.12.7768-7776.2005. PMC 1143631. PMID 15919929.

doi.org

dx.doi.org

“Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme”. 《The Biochemical Journal》 230 (3): 635–8. September 1985. doi:10.1042/bj2300635. PMC 1152665. PMID 3877502.
“IDO2 in Immunomodulation and Autoimmune Disease”. 《Frontiers in Immunology》 5: 585. 2014년 11월 20일. doi:10.3389/fimmu.2014.00585. PMC 4238401. PMID 25477879.
“Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors”. 《International Journal of Tryptophan Research》 9: 51–65. January 2016. doi:10.4137/ijtr.s38190. PMC 4982523. PMID 27547037.
“Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide”. 《Proceedings of the National Academy of Sciences of the United States of America》 75 (8): 3998–4000. August 1978. Bibcode:1978PNAS...75.3998Y. doi:10.1073/pnas.75.8.3998. PMC 392917. PMID 279015.
“Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection”. 《Proceedings of the National Academy of Sciences of the United States of America》 76 (8): 4084–6. August 1979. Bibcode:1979PNAS...76.4084Y. doi:10.1073/pnas.76.8.4084. PMC 383982. PMID 291064.
“Indoleamine 2,3 dioxygenase and metabolic control of immune responses”. 《Trends in Immunology》 34 (3): 137–43. March 2013. doi:10.1016/j.it.2012.10.001. PMC 3594632. PMID 23103127.
“Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer”. 《Cancer Immunology, Immunotherapy》 63 (7): 721–35. July 2014. doi:10.1007/s00262-014-1549-4. PMC 4384696. PMID 24711084.
“IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance”. 《Trends in Immunology》 37 (3): 193–207. March 2016. doi:10.1016/j.it.2016.01.002. PMC 4916957. PMID 26839260.
“Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”. 《Nature Medicine》 9 (10): 1269–74. October 2003. doi:10.1038/nm934. PMID 14502282.
“Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease”. 《Nature》 451 (7175): 211–5. January 2008. Bibcode:2008Natur.451..211R. doi:10.1038/nature06471. PMID 18185592.
“Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?”. 《Frontiers in Immunology》 8: 1360. 2017년 10월 27일. doi:10.3389/fimmu.2017.01360. PMC 5663846. PMID 29163470.
“Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci”. 《The Journal of Infectious Diseases》 178 (3): 875–8. September 1998. doi:10.1086/515347. PMID 9728563.
“Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections”. 《Journal of Virology》 78 (5): 2632–6. March 2004. doi:10.1128/jvi.78.5.2632-2636.2004. PMC 369218. PMID 14963171.
“Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon”. 《Journal of Virology》 79 (12): 7768–76. June 2005. doi:10.1128/jvi.79.12.7768-7776.2005. PMC 1143631. PMID 15919929.
“Prevention of allogeneic fetal rejection by tryptophan catabolism”. 《Science》 281 (5380): 1191–3. August 1998. Bibcode:1998Sci...281.1191M. doi:10.1126/science.281.5380.1191. PMID 9712583.
“Targeting the indoleamine 2,3-dioxygenase pathway in cancer”. 《Journal for Immunotherapy of Cancer》 3: 51. 2015. doi:10.1186/s40425-015-0094-9. PMC 4678703. PMID 26674411.
Munn, David H.; Shafizadeh, Ebrahim; Attwood, John T.; Bondarev, Igor; Pashine, Achal; Mellor, Andrew L. (1999년 5월 3일). “Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism”. 《The Journal of Experimental Medicine》 189 (9): 1363–1372. doi:10.1084/jem.189.9.1363. ISSN 0022-1007. PMC 2193062. PMID 10224276.
Frumento, Guido; Rotondo, Rita; Tonetti, Michela; Damonte, Gianluca; Benatti, Umberto; Ferrara, Giovanni Battista (2002년 8월 12일). “Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase”. 《The Journal of Experimental Medicine》 196 (4): 459–468. doi:10.1084/jem.20020121. ISSN 1540-9538. PMC 2196046. PMID 12186838.
Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Takao, Miho; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu (November 2007). “Ido serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells”. 《International Congress Series》 1304: 262–273. doi:10.1016/j.ics.2007.07.053. ISSN 0531-5131.
Inaba, Tomoko; Ino, Kazuhiko; Kajiyama, Hiroaki; Shibata, Kiyosumi; Yamamoto, Eiko; Kondo, Shinji; Umezu, Tomokazu; Nawa, Akihiro; Takikawa, Osamu (June 2010). “Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy”. 《Gynecologic Oncology》 117 (3): 423–428. doi:10.1016/j.ygyno.2010.02.028. ISSN 0090-8258. PMID 20350764.
Uyttenhove, Catherine; Pilotte, Luc; Théate, Ivan; Stroobant, Vincent; Colau, Didier; Parmentier, Nicolas; Boon, Thierry; Van den Eynde, Benoît J (2003년 9월 21일). “Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”. 《Nature Medicine》 9 (10): 1269–1274. doi:10.1038/nm934. ISSN 1078-8956. PMID 14502282.
Jiang, Tianze; Sun, Yingying; Yin, Zhichao; Feng, Sen; Sun, Liping; Li, Zhiyu (February 2015). “Research progress of indoleamine 2,3-dioxygenase inhibitors”. 《Future Medicinal Chemistry》 7 (2): 185–201. doi:10.4155/fmc.14.151. ISSN 1756-8919. PMID 25686005.
Muller, Alexander J; DuHadaway, James B; Donover, P Scott; Sutanto-Ward, Erika; Prendergast, George C (2005년 2월 13일). “Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy”. 《Nature Medicine》 11 (3): 312–319. doi:10.1038/nm1196. ISSN 1078-8956. PMID 15711557.
“Research progress of indoleamine 2,3-dioxygenase inhibitors”. 《Future Medicinal Chemistry》 7 (2): 185–201. 2015. doi:10.4155/fmc.14.151. PMID 25686005.
“The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis”. 《Cellular Physiology and Biochemistry》 49 (1): 134–143. 2018. doi:10.1159/000492849. PMID 30134237.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000131203 - 앙상블, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000031551 - 앙상블, May 2017

harvard.edu

adsabs.harvard.edu

“Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide”. 《Proceedings of the National Academy of Sciences of the United States of America》 75 (8): 3998–4000. August 1978. Bibcode:1978PNAS...75.3998Y. doi:10.1073/pnas.75.8.3998. PMC 392917. PMID 279015.
“Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection”. 《Proceedings of the National Academy of Sciences of the United States of America》 76 (8): 4084–6. August 1979. Bibcode:1979PNAS...76.4084Y. doi:10.1073/pnas.76.8.4084. PMC 383982. PMID 291064.
“Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease”. 《Nature》 451 (7175): 211–5. January 2008. Bibcode:2008Natur.451..211R. doi:10.1038/nature06471. PMID 18185592.
“Prevention of allogeneic fetal rejection by tryptophan catabolism”. 《Science》 281 (5380): 1191–3. August 1998. Bibcode:1998Sci...281.1191M. doi:10.1126/science.281.5380.1191. PMID 9712583.

nih.gov

ncbi.nlm.nih.gov

“Human PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
“Mouse PubMed Reference:”. 《National Center for Biotechnology Information, U.S. National Library of Medicine》.
“Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme”. 《The Biochemical Journal》 230 (3): 635–8. September 1985. doi:10.1042/bj2300635. PMC 1152665. PMID 3877502.
“Entrez Gene: INDO indoleamine-pyrrole 2,3 dioxygenase”.
“IDO2 in Immunomodulation and Autoimmune Disease”. 《Frontiers in Immunology》 5: 585. 2014년 11월 20일. doi:10.3389/fimmu.2014.00585. PMC 4238401. PMID 25477879.
“Tryptophan Metabolism in Rat Liver After Administration of Tryptophan, Kynurenine Metabolites, and Kynureninase Inhibitors”. 《International Journal of Tryptophan Research》 9: 51–65. January 2016. doi:10.4137/ijtr.s38190. PMC 4982523. PMID 27547037.
“Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide”. 《Proceedings of the National Academy of Sciences of the United States of America》 75 (8): 3998–4000. August 1978. Bibcode:1978PNAS...75.3998Y. doi:10.1073/pnas.75.8.3998. PMC 392917. PMID 279015.
“Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection”. 《Proceedings of the National Academy of Sciences of the United States of America》 76 (8): 4084–6. August 1979. Bibcode:1979PNAS...76.4084Y. doi:10.1073/pnas.76.8.4084. PMC 383982. PMID 291064.
“Indoleamine 2,3 dioxygenase and metabolic control of immune responses”. 《Trends in Immunology》 34 (3): 137–43. March 2013. doi:10.1016/j.it.2012.10.001. PMC 3594632. PMID 23103127.
“Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer”. 《Cancer Immunology, Immunotherapy》 63 (7): 721–35. July 2014. doi:10.1007/s00262-014-1549-4. PMC 4384696. PMID 24711084.
“IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance”. 《Trends in Immunology》 37 (3): 193–207. March 2016. doi:10.1016/j.it.2016.01.002. PMC 4916957. PMID 26839260.
“Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”. 《Nature Medicine》 9 (10): 1269–74. October 2003. doi:10.1038/nm934. PMID 14502282.
“Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease”. 《Nature》 451 (7175): 211–5. January 2008. Bibcode:2008Natur.451..211R. doi:10.1038/nature06471. PMID 18185592.
“Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?”. 《Frontiers in Immunology》 8: 1360. 2017년 10월 27일. doi:10.3389/fimmu.2017.01360. PMC 5663846. PMID 29163470.
“Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci”. 《The Journal of Infectious Diseases》 178 (3): 875–8. September 1998. doi:10.1086/515347. PMID 9728563.
“Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections”. 《Journal of Virology》 78 (5): 2632–6. March 2004. doi:10.1128/jvi.78.5.2632-2636.2004. PMC 369218. PMID 14963171.
“Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon”. 《Journal of Virology》 79 (12): 7768–76. June 2005. doi:10.1128/jvi.79.12.7768-7776.2005. PMC 1143631. PMID 15919929.
“Prevention of allogeneic fetal rejection by tryptophan catabolism”. 《Science》 281 (5380): 1191–3. August 1998. Bibcode:1998Sci...281.1191M. doi:10.1126/science.281.5380.1191. PMID 9712583.
“Targeting the indoleamine 2,3-dioxygenase pathway in cancer”. 《Journal for Immunotherapy of Cancer》 3: 51. 2015. doi:10.1186/s40425-015-0094-9. PMC 4678703. PMID 26674411.
Munn, David H.; Shafizadeh, Ebrahim; Attwood, John T.; Bondarev, Igor; Pashine, Achal; Mellor, Andrew L. (1999년 5월 3일). “Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism”. 《The Journal of Experimental Medicine》 189 (9): 1363–1372. doi:10.1084/jem.189.9.1363. ISSN 0022-1007. PMC 2193062. PMID 10224276.
Frumento, Guido; Rotondo, Rita; Tonetti, Michela; Damonte, Gianluca; Benatti, Umberto; Ferrara, Giovanni Battista (2002년 8월 12일). “Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase”. 《The Journal of Experimental Medicine》 196 (4): 459–468. doi:10.1084/jem.20020121. ISSN 1540-9538. PMC 2196046. PMID 12186838.
Inaba, Tomoko; Ino, Kazuhiko; Kajiyama, Hiroaki; Shibata, Kiyosumi; Yamamoto, Eiko; Kondo, Shinji; Umezu, Tomokazu; Nawa, Akihiro; Takikawa, Osamu (June 2010). “Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy”. 《Gynecologic Oncology》 117 (3): 423–428. doi:10.1016/j.ygyno.2010.02.028. ISSN 0090-8258. PMID 20350764.
Uyttenhove, Catherine; Pilotte, Luc; Théate, Ivan; Stroobant, Vincent; Colau, Didier; Parmentier, Nicolas; Boon, Thierry; Van den Eynde, Benoît J (2003년 9월 21일). “Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”. 《Nature Medicine》 9 (10): 1269–1274. doi:10.1038/nm934. ISSN 1078-8956. PMID 14502282.
Jiang, Tianze; Sun, Yingying; Yin, Zhichao; Feng, Sen; Sun, Liping; Li, Zhiyu (February 2015). “Research progress of indoleamine 2,3-dioxygenase inhibitors”. 《Future Medicinal Chemistry》 7 (2): 185–201. doi:10.4155/fmc.14.151. ISSN 1756-8919. PMID 25686005.
Muller, Alexander J; DuHadaway, James B; Donover, P Scott; Sutanto-Ward, Erika; Prendergast, George C (2005년 2월 13일). “Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy”. 《Nature Medicine》 11 (3): 312–319. doi:10.1038/nm1196. ISSN 1078-8956. PMID 15711557.
“Research progress of indoleamine 2,3-dioxygenase inhibitors”. 《Future Medicinal Chemistry》 7 (2): 185–201. 2015. doi:10.4155/fmc.14.151. PMID 25686005.
“The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis”. 《Cellular Physiology and Biochemistry》 49 (1): 134–143. 2018. doi:10.1159/000492849. PMID 30134237.

worldcat.org

Munn, David H.; Shafizadeh, Ebrahim; Attwood, John T.; Bondarev, Igor; Pashine, Achal; Mellor, Andrew L. (1999년 5월 3일). “Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism”. 《The Journal of Experimental Medicine》 189 (9): 1363–1372. doi:10.1084/jem.189.9.1363. ISSN 0022-1007. PMC 2193062. PMID 10224276.
Frumento, Guido; Rotondo, Rita; Tonetti, Michela; Damonte, Gianluca; Benatti, Umberto; Ferrara, Giovanni Battista (2002년 8월 12일). “Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase”. 《The Journal of Experimental Medicine》 196 (4): 459–468. doi:10.1084/jem.20020121. ISSN 1540-9538. PMC 2196046. PMID 12186838.
Okamoto, Aikou; Nikaido, Takashi; Ochiai, Kazunori; Takakura, Satoshi; Takao, Miho; Saito, Misato; Aoki, Yuko; Ishii, Nobuya; Yanaihara, Nozomu (November 2007). “Ido serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells”. 《International Congress Series》 1304: 262–273. doi:10.1016/j.ics.2007.07.053. ISSN 0531-5131.
Inaba, Tomoko; Ino, Kazuhiko; Kajiyama, Hiroaki; Shibata, Kiyosumi; Yamamoto, Eiko; Kondo, Shinji; Umezu, Tomokazu; Nawa, Akihiro; Takikawa, Osamu (June 2010). “Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy”. 《Gynecologic Oncology》 117 (3): 423–428. doi:10.1016/j.ygyno.2010.02.028. ISSN 0090-8258. PMID 20350764.
Uyttenhove, Catherine; Pilotte, Luc; Théate, Ivan; Stroobant, Vincent; Colau, Didier; Parmentier, Nicolas; Boon, Thierry; Van den Eynde, Benoît J (2003년 9월 21일). “Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase”. 《Nature Medicine》 9 (10): 1269–1274. doi:10.1038/nm934. ISSN 1078-8956. PMID 14502282.
Jiang, Tianze; Sun, Yingying; Yin, Zhichao; Feng, Sen; Sun, Liping; Li, Zhiyu (February 2015). “Research progress of indoleamine 2,3-dioxygenase inhibitors”. 《Future Medicinal Chemistry》 7 (2): 185–201. doi:10.4155/fmc.14.151. ISSN 1756-8919. PMID 25686005.
Muller, Alexander J; DuHadaway, James B; Donover, P Scott; Sutanto-Ward, Erika; Prendergast, George C (2005년 2월 13일). “Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy”. 《Nature Medicine》 11 (3): 312–319. doi:10.1038/nm1196. ISSN 1078-8956. PMID 15711557.